Showing results (381-390 of 445) with videos related to

Sort By:
Pageof 45
Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
Journal of Neuro-Oncology|October 2, 2017
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patientsDaniel I Jacobs, Yanhong Liu, Konrad Gabrusiewicz, et al.
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
NPJ Digital Medicine|August 7, 2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRINate Tran, Tracy L Luks, Yan Li, et al.
Neuro-Oncology|June 15, 2023
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine gliomaSabine Mueller, Cassie Kline, Schuyler Stoller, et al.
Neurosurgery|January 4, 2022
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type GlioblastomaAlexander A Aabedi, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.
Pageof 45